AGC Pharma Chemicals Euro

AGC Pharma Chemicals, with operations in Spain and Japan, is a reliable CDMO (Contract Development Manufacturing Organization) serving the global pharmaceutical industry with small molecule APIs and intermediates. We excel in delivering top pharma quality operations. With over 60 years as API manufacturers and more than 40 years of experience as a small molecule CDMO, we have built an unmatched legacy in the industry.
Reliability is our top priority. Our commitment to quality is evident, with more than 20 years of operations free from FDA 483 observations and no critical or major findings. Adhering to the highest quality standards is ingrained in every aspect of our processes.
We ensure that our integrated, end-to-end solutions are agile and flexible, adapting seamlessly from lab to scalable production capacity. This adaptability is crucial for the success of any API project, enabling scale-up from grams to tons and supporting the full lifecycle from clinical phase I to commercialization.
As pioneers in the field, AGC Pharma Chemicals leads the industry with innovative routes of synthesis, tackling complex challenges with cutting-edge solutions that ensure superior API and intermediate development. Our extensive knowledge and experience, particularly in the field of fluorinated substances, position us at the forefront of chemical innovation, backed by over 100 years of expertise as a chemical company.
AGC Pharma Chemicals has solid business growth and financial stability as a part of AGC Group, formerly Asahi Glass Company. AGC Group is a global business conglomerate with over 200 companies, more than 55,800 employees and extending into over 30 countries.